Furthermore, the knockdown of EZH2-mediated BMPR1B stimulated maintenance of CSCs in a subset of GBM, signifying that BMPR1B was responsible for the reduction in tumorigenic potential in EZH2-knockdown BT-CSC (Figure 2) [81]. The gene discussed is EZH2; the disease is glioblastoma.